UnitedHealth (UNH) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
UnitedHealth (UNH) quarterly earnings & revenue
UnitedHealth (UNH) reported revenue of $112.03B for Q2 2026, up 0.4% year-over-year, with net income of $5.48B and diluted EPS of $6.05.
Over the last four reported quarters, UnitedHealth generated $450.13B in revenue and $14.12B in net income.
UnitedHealth's next earnings report is scheduled for October 27, 2026 before market open; analysts estimate EPS of $4.06.
UnitedHealth quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q2 2026 | $112.03B | +0.4% | $5.48B | $6.05 |
| Q1 2026 | $111.72B | +2.0% | $6.28B | $6.90 |
| Q4 2025 | $113.22B | +12.3% | $10.00M | $0.01 |
| Q3 2025 | $113.16B | +12.2% | $2.35B | $2.59 |
| Q2 2025 | $111.62B | +12.9% | $3.41B | $3.74 |
| Q1 2025 | $109.58B | +9.8% | $6.29B | $6.85 |
| Q4 2024 | $100.81B | +6.8% | $5.54B | $5.98 |
| Q3 2024 | $100.82B | +9.2% | $6.05B | $6.51 |
UnitedHealth (UNH) — frequently asked questions
When does UnitedHealth (UNH) report earnings next?
UnitedHealth is expected to report earnings on October 27, 2026 before market open. Analysts estimate EPS of $4.06.
What was UNH's revenue last quarter?
UnitedHealth reported revenue of $112.03B in Q2 2026, up 0.4% from the same quarter a year earlier.
What was UNH's EPS last quarter?
UnitedHealth reported diluted EPS of $6.05 in Q2 2026.
Is UnitedHealth profitable?
UnitedHealth is currently profitable, with $14.12B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · Roche (ROG.SW) · Novartis (NVS)